Drug General Information |
Drug ID |
D09RFE
|
Former ID |
DNC007914
|
Drug Name |
4-(3-phenoxylphenyl)-5-cyano-2H-1,2,3-triazole
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C15H10N4O
|
Canonical SMILES |
C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=NNN=C3C#N
|
InChI |
1S/C15H10N4O/c16-10-14-15(18-19-17-14)11-6-8-13(9-7-11)20-12-4-2-1-3-5-12/h1-9H,(H,17,18,19)
|
InChIKey |
LHOBXXROLCTUBM-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
mRNA of HER2 |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
ErbB signaling pathway
|
Calcium signaling pathway
|
HIF-1 signaling pathway
|
Focal adhesion
|
Adherens junction
|
Pathways in cancer
|
Proteoglycans in cancer
|
MicroRNAs in cancer
|
Pancreatic cancer
|
Endometrial cancer
|
Prostate cancer
|
Bladder cancer
|
Non-small cell lung cancer
|
Central carbon metabolism in cancer
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Cadherin signaling pathway
|
EGF receptor signaling pathway
|
Pathway Interaction Database
|
ErbB4 signaling events
|
ErbB2/ErbB3 signaling events
|
ErbB receptor signaling network
|
a6b1 and a6b4 Integrin signaling
|
Validated targets of C-MYC transcriptional repression
|
PathWhiz Pathway
|
Phosphatidylinositol Phosphate Metabolism
|
Reactome
|
SHC1 events in ERBB2 signaling
|
PLCG1 events in ERBB2 signaling
|
PIP3 activates AKT signaling
|
GRB2 events in ERBB2 signaling
|
PI3K events in ERBB2 signaling
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
Sema4D induced cell migration and growth-cone collapse
|
RAF/MAP kinase cascade
|
WikiPathways
|
DNA Damage Response (only ATM dependent)
|
ErbB Signaling Pathway
|
EGF/EGFR Signaling Pathway
|
Extracellular vesicle-mediated signaling in recipient cells
|
Bladder Cancer
|
Signaling by ERBB2
|
Integrated Pancreatic Cancer Pathway
|
Signaling Pathways in Glioblastoma
|
Leptin signaling pathway
|
miR-targeted genes in muscle cell - TarBase
|
Semaphorin interactions
|
References |
REF 1 | Bioorg Med Chem. 2007 Feb 1;15(3):1533-8. Epub 2006 Dec 15.Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3-triazoles as inhibitor of HER2 tyrosine kinase. |